UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
Decker, Richard C.
2728 N. Harwood
Dallas, TX 75201
USA
2. Issuer Name and Ticker or Trading Symbol
Centex Development Company, L.P.
trades in tandem with Centex Corporation - CTX
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. Statement for Month/Year
7/31/98
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
(X) Director ( ) 10% Owner (X) Officer (give title below) ( ) Other
(specify below)
President & Director of 3333 Development Co., General Partner of Centex
Development Company, L.P.
7. Individual or Joint/Group Filing (Check Applicable Line)
(X) Form filed by One Reporting Person
( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1. Title of Security |2. |3. |4.Securities Acquired (A) |5.Amount of |6.Dir |7.Nature of Indirect |
| Transaction | or Disposed of (D) | Securities |ect | Beneficial Ownership |
| | | | Beneficially |(D)or | |
| | | | | A/| | Owned at |Indir | |
| Date |Code|V| Amount | D | Price | End of Month |ect(I)| |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C><C> <C> <C> <C> <C> <C>
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con- |3. |4. |5.Number of De |6.Date Exer|7.Title and Amount |8.Price|9.Number |10.|11.Nature of|
Security |version |Transaction | rivative Secu |cisable and| of Underlying |of Deri|of Deriva |Dir|Indirect |
|or Exer | | | rities Acqui |Expiration | Securities |vative |tive |ect|Beneficial |
|cise | | | red(A) or Dis |Date(Month/| |Secu |Securities |(D)|Ownership |
|Price of| | | posed of(D) |Day/Year) | |rity |Benefi |or | |
|Deriva- | | | |Date |Expir| | |ficially |Ind| |
|tive | | | | A/|Exer-|ation| Title and Number | |Owned at |ire| |
|Secu- | | | | | D |cisa-|Date | of Shares | |End of |ct | |
|rity |Date |Code|V| Amount | |ble | | | |Month |(I)| |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C> <C><C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Option Right to Buy |$38.6875|4/1/9|A |V|0.1511 |A |_____|4/1/2|Warrants to |0.1511 | |0.1511(2) |D | |
| |8 | | | | |(1) |008 |Purchase Uni| | | | | |
| | | | | | | | |ts | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | | | | | | | | | |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1) Exercisable: 1,800 shares of Centex Common Stock (.0272 Warrants to
Purchase Class B Units) each on April
1, 1998, 1999, 2000, 2001 and
2002.
(2) Pursuant to a Nominee Agreement dated November 30, 1987, each person who is
the beneficial owner of
shares of Centex Corporation ("Centex") Common Stock is also the beneficial
owner of an undivided interest in
900 warrants (the "Warrants") to purchase Class B units of limited partnership
interest in Centex Development
Company, L.P. ("CDC") at an exercise price of $500 per Class B unit, which
Warrants are held of record by
Chemical Bank as successor nominee. Each benefical owner's proportionate
interest in the Warrants is equal to
the number of shares of Centex Common Stock he owns divided by the total number
of shares of Centex Common
Stock outstanding from time to time. The exercise price for the Warrants will
be determined at the time they become
exercisable based on the number of Warrants that are then exercisable, the
manner in which the Warrants are
subdivided is at the discretion of the general partner of CDC and the humber of
shares of Centex Common Stock
outstanding at that time. The Warrants will be exercisable for a 90-day period
commencing on a date to be
extended by a vote of the Centex stockholders. Until the Nominee Agreement is
terminated with respect to the
Warrants and certificates evidencing the Warrants are issued in the name of the
beneficial owners thereof, the
Reporting Person has no right to obtain a certificate evidencing his beneficial
interest in the Warrants or to dispose
of the Warrants separate from Centex Common Stock. Computations set forth in
this Form have been made using
59,555,506 shares of Centex Common Stock outstanding as reported in Centex
Corporation's Form 10-K for fiscal
quarter ending March 31,
1998.
SIGNATURE OF REPORTING PERSON
/s/ Richard C. Decker
DATE
August 7, 1998
